<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04849624</url>
  </required_header>
  <id_info>
    <org_study_id>2019615-7520-3</org_study_id>
    <nct_id>NCT04849624</nct_id>
  </id_info>
  <brief_title>Body Composition Study in Critically Ill Patients-Extended to COVID-19</brief_title>
  <acronym>COVID-MUSCLE</acronym>
  <official_title>Body Composition Study in Critically Ill Patients-Extended to COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Malaya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Malaya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Muscle loss (ultrasound quadricep muscle) and muscle strength (handgrip and knee extension&#xD;
      strength) will be compared between COVID-19 and non COVID-19 critically ill patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Given the heightened inflammatory status among COVID-19 critically ill patients, we&#xD;
      hypothesized that the rate of skeletal muscle loss is accelerated in this population, and&#xD;
      this loss is even more pronounce than the general critically ill patients. We further&#xD;
      hypothesized that the increased muscle loss will lead to worse functional outcome (lower&#xD;
      muscle strength) in COVID-19 critically ill patients compared with age- and sex-matched&#xD;
      non-COVID-19 critically ill patients, as it has been shown that quadriceps thickness is&#xD;
      strongly correlated with functional status at ICU discharge. Furthermore, a recent systematic&#xD;
      review and meta-analysis in survivors of coronavirus (severe acute respiratory syndrome, SARS&#xD;
      or Middle-east respiratory syndrome, MERS, or COVID-19) also demonstrated reduced exercise&#xD;
      capacity and quality of life at 6 months after hospitalization or ICU admission&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rectus Femoris Thickness</measure>
    <time_frame>Change in Rectus Femoris Thickness at day 7 or ICU discharge or hospital discharge compared with baseline (Day 1 of ICU admission)</time_frame>
    <description>Change in Rectus Femoris Thickness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rectus Femoris Cross-sectional Area</measure>
    <time_frame>Change in Rectus Femoris Cross-sectional Area at day 7 or ICU discharge or hospital discharge compared with baseline (Day 1 of ICU admission)</time_frame>
    <description>Change in Rectus Femoris Cross-sectional Area</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Forearm Muscle Thickness</measure>
    <time_frame>Change in Forearm Muscle Thickness at day 7 or ICU discharge or hospital discharge compared with baseline (Day 1 of ICU admission)</time_frame>
    <description>Change in Forearm Muscle Thickness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Handgrip Strength</measure>
    <time_frame>Before Hospital Discharge</time_frame>
    <description>BIlateral Handgrip Strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Extension Strength</measure>
    <time_frame>Before Hospital Discharge</time_frame>
    <description>BIlateral Knee Extension Strength</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Mortality</measure>
    <time_frame>Mortality at day 28 (calculated from the first day of ICU admission)</time_frame>
    <description>28-day Mortality</description>
  </other_outcome>
  <other_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>From date of enrolment until the date of discharged from the ICU, assessed up to 60 days</time_frame>
    <description>Length of stay in the ICU</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>From date of enrolment until the date of discharged from the hospital, assessed up to 60 days</time_frame>
    <description>Length of stay in the Hospital</description>
  </other_outcome>
  <other_outcome>
    <measure>Length of Mechanical Ventilation</measure>
    <time_frame>From date of commencement of mechanical ventilation until the date of liberation from mechanical ventilation, assessed up to 60 days</time_frame>
    <description>Duration of Mechanical Ventilation</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Critical Illness</condition>
  <condition>Covid19</condition>
  <condition>Muscle Atrophy</condition>
  <condition>Muscle Strength</condition>
  <arm_group>
    <arm_group_label>ICU COVID-19 patients</arm_group_label>
    <description>COVID-19 patients that are admitted into the ICU and fulfilled the eligibility criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICU non-COVID-19 patients</arm_group_label>
    <description>Non-COVID-19 patients that are admitted into the ICU matched with ICU COVID-19 patients that are recruited and fulfilled the eligibility criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention</intervention_name>
    <description>This is an observational study and involved no intervention</description>
    <arm_group_label>ICU COVID-19 patients</arm_group_label>
    <arm_group_label>ICU non-COVID-19 patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 30 COVID-19 ICU patients as per the eligibility criteria will be recruited. A&#xD;
        total of 20 non-COVID-19 ICU patients that are matched by age (+/- 10 years old), sex and&#xD;
        ventilation mode (mostly will be with lung pathology) will be enrolled to compare their&#xD;
        change in muscle mass and muscle strength at hospital discharge with COVID-19 ICU patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  â‰¥ 18 years old&#xD;
&#xD;
          -  Admitted into the ICU due to COVID-19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Likely to transfer out from the ICU in 24 hours from screening&#xD;
&#xD;
          -  Likely to die in the next 7 days&#xD;
&#xD;
          -  Bedbound prior to hospital admission or bedbound in the hospital for &gt;10 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Medicine, University of Malaya</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50603</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zheng Yii Lee</last_name>
      <phone>+60169754153</phone>
      <email>zheng_yii@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <reference>
    <citation>Lee ZY, Ong SP, Ng CC, Yap CSL, Engkasan JP, Barakatun-Nisak MY, Heyland DK, Hasan MS. Association between ultrasound quadriceps muscle status with premorbid functional status and 60-day mortality in mechanically ventilated critically ill patient: A single-center prospective observational study. Clin Nutr. 2021 Mar;40(3):1338-1347. doi: 10.1016/j.clnu.2020.08.022. Epub 2020 Aug 28.</citation>
    <PMID>32919818</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 18, 2021</study_first_submitted>
  <study_first_submitted_qc>April 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>April 15, 2021</last_update_submitted>
  <last_update_submitted_qc>April 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

